Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage.
Document Type
Article
Publication Date
4-9-2023
Publication Title
Cureus
Abstract
Hydralazine is a potent vasodilating medication used as adjunctive therapy for the treatment of hypertension. Rarely, hydralazine may cause the development of antineutrophil cytoplasmic antibody vasculitis with the pulmonary-renal syndrome. We are presenting a case of hydralazine-associated vasculitis and pulmonary hemorrhage.
Volume
15
Issue
4
First Page
37332
Last Page
37332
Recommended Citation
Strubchevska K, Kozyk M, Jacobs MR, White D. Hydralazine-associated vasculitis and pulmonary hemorrhage. Cureus. 2023 Apr 9;15(4):e37332. doi: 10.7759/cureus.37332. PMID: 37182038.
DOI
0.7759/cureus.37332
ISSN
2168-8184
PubMed ID
37182038
COinS